BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35243327)

  • 1. Small-volume
    Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
    Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
    Salim M; Fraser-Miller SJ; Be Rziņš KR; Sutton JJ; Ramirez G; Clulow AJ; Hawley A; Beilles S; Gordon KC; Boyd BJ
    Mol Pharm; 2020 Mar; 17(3):885-899. PubMed ID: 32011151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-State Behavior and Solubilization of Flash Nanoprecipitated Clofazimine Particles during the Dispersion and Digestion of Milk-Based Formulations.
    Salim M; Ramirez G; Clulow AJ; Zhang Y; Ristroph KD; Feng J; McManus SA; Hawley A; Prud'homme RK; Boyd BJ
    Mol Pharm; 2019 Jun; 16(6):2755-2765. PubMed ID: 31038976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
    Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
    Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
    Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
    Khan J; Hawley A; Rades T; Boyd BJ
    J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs.
    Boyd BJ; Salim M; Clulow AJ; Ramirez G; Pham AC; Hawley A
    J Control Release; 2018 Dec; 292():13-17. PubMed ID: 30359667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
    Khan J; Rades T; Boyd BJ
    Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating human milk as a drug delivery vehicle for clofazimine to premature infants.
    Ponsonby-Thomas E; Salim M; Klein LD; Clulow AJ; Seibt S; Boyd BJ
    J Control Release; 2023 Oct; 362():257-267. PubMed ID: 37619865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
    Thomas N; Holm R; Müllertz A; Rades T
    J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
    Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Situ Monitoring of Drug Precipitation from Digesting Lipid Formulations Using Low-Frequency Raman Scattering Spectroscopy.
    Salim M; Fraser-Miller SJ; Bērziņš K; Sutton JJ; Gordon KC; Boyd BJ
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
    Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic lipolysis rate for systematic design of lipid-based formulations.
    Jacobsen AC; Kabedev A; Sinko PD; Palm JE; Bergström CAS; Teleki A
    Drug Deliv Transl Res; 2023 May; 13(5):1288-1304. PubMed ID: 36209313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.